ATF2 and Parkinson disease: Findings from preclinical study illustrated that metformin protected dopaminergic neurons and improved dopamine‐sensitive motor performance in an MPTP‐induced PD animal model via ATF2/CREB‐PGC‐1α pathway (Kang et al. 2017).